Honasa buys 58% of Fluence Pharma, opens nutraceuticals front beyond Mamaearth
Mamaearth parent Honasa Consumer is acquiring a 58% stake in Fluence Pharma, pushing the D2C beauty house into nutraceuticals. The move signals a category-stretch playbook as core personal care growth moderates, with Honasa betting adjacent wellness SKUs can ride the same digital-first distribution.
Honasa Consumer (Mamaearth parent) acquires 58% in Fluence Pharma, entering nutraceuticals. Bajaj Auto trades ex-buyback. Imagicaa Water Park reopens June 26 in Khopoli. Rashi Peripherals acquires 67% in VDA Infosolutions for Rs 368.5 crore.